SHELBI NAVARRETTE: Open Payments
NPI 1285178517 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 52 payments from 15 companies in 2025. Trend: 2023 $954 · 2024 $1,135 · 2025 $1,199
Food & beverage: $1,199
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $330 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $299 |
| AstraZeneca Pharmaceuticals LP | 3 | $181 |
| Corcept Therapeutics | 3 | $65 |
| ABBVIE INC. | 3 | $62 |
| Insulet Corporation | 3 | $56 |
| PFIZER INC. | 3 | $48 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
Products named: CAPLYTA, Ozempic, BREZTRI, Rybelsus, Korlym, Omnipod, NURTEC ODT, UBRELVY.
Industry payments across KY — which companies pay providers there.
